What is iGenetic Diagnostics?
Headquartered in Mumbai, iGenetic Diagnostics is at the forefront of pathological investigations, offering a comprehensive suite of specialized cytogenetic and molecular tests. Their expertise spans oncology, critical care, gynaecology, and neurology, serving the Indian population through an accredited central laboratory and a network of facilities. With a test menu exceeding 1400 investigations, iGenetic Diagnostics is committed to integrating cutting-edge technologies to enhance diagnostic accuracy and accessibility.
How much funding has iGenetic Diagnostics raised?
iGenetic Diagnostics has raised a total of $20.5M across 2 funding rounds:
Angel/Seed
$1M
Private Equity
$19.5M
Angel/Seed (2016): $1M, investors not publicly disclosed
Private Equity (2017): $19.5M led by Manipal Education and Medical Group and CDC Group Plc
Key Investors in iGenetic Diagnostics
Manipal Education and Medical Group
Manipal Education and Medical Group is a significant entity in India's education and healthcare sectors, operating multiple universities and healthcare facilities. Their investment likely aligns with a strategic interest in advancing medical diagnostics and research within India.
What's next for iGenetic Diagnostics?
The recent major strategic investment signals a pivotal phase for iGenetic Diagnostics, likely enabling expansion of its operational footprint, enhancement of its technological capabilities, and further development of its extensive test menu. This capital infusion is expected to accelerate the company's mission to introduce advanced diagnostic solutions tailored for the Indian demographic, solidifying its position as a leader in the healthcare diagnostics industry.
See full iGenetic Diagnostics company page
